Leibniz Research Alliance
Healthy Ageing

© Quelle: llja Hendel / Wissenschaft im Dialog

News & Research findings

Additional 5 Million Euro Funding for Aging Research in Jena, Germany

09/03/2018 FLI Leibniz Institute on Aging - Fritz Lipmann Institute

The Leibniz Institute on Aging (FLI) in Jena, Germany, was approved 5 million EUR additional funding by the German Joint Science Conference (Gemeinsame Wissenschaftskonferenz, GWK), which thus... more info

Cancer or degenerative diseases?

31/01/2018 FLI Leibniz Institute on Aging

Above the age of 50, the most likely causes of death are cancer and degenerative diseases such as heart failure, dementia or diabetes. Since life expectancy has been considerably growing over the... more info

Molecular Chaperones Shown to Assist in the Fight against Huntington Disease

12/12/2017 FMP Leibniz-Forschungsinstitut für Molekulare Pharmakologie

Huntington’s disease is a neurodegenerative disease. It is always fatal. The disease is caused by a defect in the Huntingtin gene. To this day, no therapy will put... more info

Tracking the effects of air pollution on the brain

14/09/2017 IUF Leibniz Institute for Environmental Medicine

Researchers from the IUF – Leibniz Research Institute for Environmental Medicine in Düsseldorf (Germany) showed in collaboration with the Dutch National Institute for Public Health and the... more info

Enzyme produced in the liver promotes obesity, fatty liver disease and insulin resistance

23/08/2017 DIfE German Institute Human Nutrition Potsdam-Rehbrücke

In mice that are given a high-fat diet, an increased production of the enzyme DPP4* by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance.... more info

GSCN awards “Young Investigator Award“ for FLI-Scientist Francesco Neri

21/08/2017 FLI Leibniz Institute on Aging - Fritz Lipmann Institute

Francesco Neri, PhD, research group leader at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena, receives the „GSCN 2017 Young Investigator Award“ of the German Stem Cell Network. more info

New therapeutic attack point: Scientists find off-switch for the mTor complex

06/06/2017 FMP Leibniz-Institut für Molekulare Pharmakologie

As the cell's molecular control center, the mTor kinase regulates cellular metabolism, growth and division. However, in cells affected by pathological change, the regulation goes array. Therefore, it... more info

    Press contact

    Astrid van der Wall
    FLI Leibniz Institute on Aging - Fritz Lipmann Institute
    Phone: ++49 (0)3641 - 65 63 14
    healthyageing(at)leibniz-fli.de